Staff

Stem Cell Manufacturing Market – 42% of Growth to Originate from North America| Evolving opportunities with Becton Dickinson and Co. & Bio Techne Corp.| 17000+ Technavio Reports

Secarna Pharmaceuticals’ Partner Denali Therapeutics Exercises Option for LNAplusTM Antisense Oligonucleotide Development Program in Neurodegeneration

First development program for which Denali exercised an option under the ongoing and recently expanded collaborationSecarna's LNAplusTM antisense oligonucleotides (ASOs)...

error: Content is protected !!